The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gajewski, T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gajewski, T. F.
Right arrowPubmed/NCBI databases
*Substance via MeSH

The Journal of Immunology, Vol 156, Issue 2 465-472, Copyright © 1996 by American Association of Immunologists

ARTICLES

B7-1 but not B7-2 efficiently costimulates CD8+ T lymphocytes in the P815 tumor system in vitro

TF Gajewski
Ludwig Institute for Cancer Research, Brussels Branch, Catholic University of Louvain, Belgium.

We recently have developed a method to generate primary P815-specific CTL in vitro from normal syngeneic splenocytes by employing transfection of B7-1 combined with exogenous IL-12 and IL-6. Surprisingly, when the homologous costimulator molecule B7-2 was substituted for B7-1 in this system, no specific CTL activity was obtained. Similarly, B7-1- but not B7-2-transfected P815 cells generated alloantigen-specific CTL activity from C57BL/6, accessory cell- and CD4(+)-depleted splenocytes, and costimulated proliferation of CD8+ lymphocytes in the presence of low doses of anti-CD3 mAb. In all systems, combined expression of both B7-1 and B7-2 costimulated as effectively as B7-1 alone, arguing against delivery of a dominant negative signal by B7-2. Proliferation of allogeneic, CD4(+)-depleted splenocytes in response to P815 cells, which relies on costimulation by normal accessory cells, was inhibited by anti-B7-1 but not anti-B7-2 mAbs. Finally, indirect evidence suggested a higher avidity of B7-1+ cells than B7-2+ cells for CTLA4. Thus, at least in the context of primary stimulation by irradiated P815 transfectants, B7-1 appears to be superior to B7-2 at costimulation of CD8+ T lymphocytes.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
S. Pejawar-Gaddy and M. A. Alexander-Miller
Ligation of CD80 Is Critical for High-Level CD25 Expression on CD8+ T Lymphocytes
J. Immunol., October 1, 2006; 177(7): 4495 - 4502.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. E. Brown, C. Blank, J. Kline, A. K. Kacha, and T. F. Gajewski
Homeostatic Proliferation as an Isolated Variable Reverses CD8+ T Cell Anergy and Promotes Tumor Rejection
J. Immunol., October 1, 2006; 177(7): 4521 - 4529.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Schneider, E. Valk, S. da Rocha Dias, B. Wei, and C. E. Rudd
CTLA-4 up-regulation of lymphocyte function-associated antigen 1 adhesion and clustering as an alternate basis for coreceptor function
PNAS, September 6, 2005; 102(36): 12861 - 12866.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. S. Pejawar, G. D. Parks, and M. A. Alexander-Miller
Abortive versus Productive Viral Infection of Dendritic Cells with a Paramyxovirus Results in Differential Upregulation of Select Costimulatory Molecules
J. Virol., June 15, 2005; 79(12): 7544 - 7557.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Blank, I. Brown, A. K. Kacha, M. A. Markiewicz, and T. F. Gajewski
ICAM-1 Contributes to but Is Not Essential for Tumor Antigen Cross-Priming and CD8+ T Cell-Mediated Tumor Rejection In Vivo
J. Immunol., March 15, 2005; 174(6): 3416 - 3420.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Blank, I. Brown, A. C. Peterson, M. Spiotto, Y. Iwai, T. Honjo, and T. F. Gajewski
PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T Cells
Cancer Res., February 1, 2004; 64(3): 1140 - 1145.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Blank, I. Brown, R. Marks, H. Nishimura, T. Honjo, and T. F. Gajewski
Absence of Programmed Death Receptor 1 Alters Thymic Development and Enhances Generation of CD4/CD8 Double-Negative TCR-Transgenic T Cells
J. Immunol., November 1, 2003; 171(9): 4574 - 4581.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. G. Agadjanyan, M. A. Chattergoon, M. J. Holterman, B. Monzavi-Karbassi, J. J. Kim, T. Dentchev, D. Wilson, V. Ayyavoo, L. J. Montaner, T. Kieber-Emmons, et al.
Costimulatory Molecule Immune Enhancement in a Plasmid Vaccine Model Is Regulated in Part Through the Ig Constant-Like Domain of CD80/86
J. Immunol., October 15, 2003; 171(8): 4311 - 4319.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. M. M. Haeryfar, M. M. Al-alwan, J. S. Mader, G. Rowden, K. A. West, and D. W. Hoskin
Thy-1 Signaling in the Context of Costimulation Provided by Dendritic Cells Provides Signal 1 for T Cell Proliferation and Cytotoxic Effector Molecule Expression, but Fails to Trigger Delivery of the Lethal Hit
J. Immunol., July 1, 2003; 171(1): 69 - 77.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. W. Hwang, W. B. Sweatt, I. E. Brown, C. Blank, T. F. Gajewski, J. A. Bluestone, and M.-L. Alegre
Cutting Edge: Targeted Ligation of CTLA-4 In Vivo by Membrane-Bound Anti-CTLA-4 Antibody Prevents Rejection of Allogeneic Cells
J. Immunol., July 15, 2002; 169(2): 633 - 637.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. L. LaBelle, C. A. Hanke, B. R. Blazar, and R. L. Truitt
Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemia
Blood, March 15, 2002; 99(6): 2146 - 2153.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H.-W. Mittrucker, M. Kursar, A. Kohler, R. Hurwitz, and S. H. E. Kaufmann
Role of CD28 for the Generation and Expansion of Antigen-Specific CD8+ T Lymphocytes During Infection with Listeria monocytogenes
J. Immunol., November 15, 2001; 167(10): 5620 - 5627.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. F. Staats, C. P. Bradney, W. M. Gwinn, S. S. Jackson, G. D. Sempowski, H.-X. Liao, N. L. Letvin, and B. F. Haynes
Cytokine Requirements for Induction of Systemic and Mucosal CTL After Nasal Immunization
J. Immunol., November 1, 2001; 167(9): 5386 - 5394.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Donepudi, P. Raychaudhuri, J. A. Bluestone, and M. B. Mokyr
Mechanism of Melphalan-Induced B7-1 Gene Expression in P815 Tumor Cells
J. Immunol., June 1, 2001; 166(11): 6491 - 6499.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Notter, T. Willinger, U. Erben, and E. Thiel
Targeting of a B7-1 (CD80) immunoglobulin G fusion protein to acute myeloid leukemia blasts increases their costimulatory activity for autologous remission T cells
Blood, May 15, 2001; 97(10): 3138 - 3145.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Chan, D. J. Lee, A. Schubert, C. M. Tang, B. Crain, S. P. Schoenberger, and M. Corr
The Roles of MHC Class II, CD40, and B7 Costimulation in CTL Induction by Plasmid DNA
J. Immunol., March 1, 2001; 166(5): 3061 - 3066.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Santra, D. H. Barouch, S. S. Jackson, M. J. Kuroda, J. E. Schmitz, M. A. Lifton, A. H. Sharpe, and N. L. Letvin
Functional Equivalency of B7-1 and B7-2 for Costimulating Plasmid DNA Vaccine-Elicited CTL Responses
J. Immunol., December 15, 2000; 165(12): 6791 - 6795.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. J. McAdam, B. E. Gewurz, E. A. Farkash, and A. H. Sharpe
Either B7 Costimulation or IL-2 Can Elicit Generation of Primary Alloreactive CTL
J. Immunol., September 15, 2000; 165(6): 3088 - 3093.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. K. Sojka, M. Donepudi, J. A. Bluestone, and M. B. Mokyr
Melphalan and Other Anticancer Modalities Up-Regulate B7-1 Gene Expression in Tumor Cells
J. Immunol., June 15, 2000; 164(12): 6230 - 6236.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Mozdzanowska, K. Maiese, and W. Gerhard
Th Cell-Deficient Mice Control Influenza Virus Infection More Effectively Than Th- and B Cell-Deficient Mice: Evidence for a Th-Independent Contribution by B Cells to Virus Clearance
J. Immunol., March 1, 2000; 164(5): 2635 - 2643.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Wang, R. Maile, R. Greenwood, E. J. Collins, and J. A. Frelinger
Naive CD8+ T Cells Do Not Require Costimulation for Proliferation and Differentiation into Cytotoxic Effector Cells
J. Immunol., February 1, 2000; 164(3): 1216 - 1222.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Martin-Fontecha, M. Moro, M. C. Crosti, F. Veglia, G. Casorati, and P. Dellabona
Vaccination with Mouse Mammary Adenocarcinoma Cells Coexpressing B7-1 (CD80) and B7-2 (CD86) Discloses the Dominant Effect of B7-1 in the Induction of Antitumor Immunity
J. Immunol., January 15, 2000; 164(2): 698 - 704.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. J. McAdam, E. A. Farkash, B. E. Gewurz, and A. H. Sharpe
B7 Costimulation Is Critical for Antibody Class Switching and CD8+ Cytotoxic T-Lymphocyte Generation in the Host Response to Vesicular Stomatitis Virus
J. Virol., January 1, 2000; 74(1): 203 - 208.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
M. Moro, A. M. Gasparri, S. Pagano, M. Bellone, P. Tornaghi, F. Veglia, A. Corti, G. Casorati, and P. Dellabona
Induction of Therapeutic T-Cell Immunity by Tumor Targeting with Soluble Recombinant B7-Immunoglobulin Costimulatory Molecules
Cancer Res., June 1, 1999; 59(11): 2650 - 2656.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. K. Martin, J. G. Frelinger, and J. P.-Y. Ting
Combination Gene Therapy with CD86 and the MHC Class II Transactivator in the Control of Lung Tumor Growth
J. Immunol., June 1, 1999; 162(11): 6663 - 6670.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B.-a. Guinn, M. A. DeBenedette, T. H. Watts, and N. L. Berinstein
4-1BBL Cooperates with B7-1 and B7-2 in Converting a B Cell Lymphoma Cell Line into a Long-Lasting Antitumor Vaccine
J. Immunol., April 15, 1999; 162(8): 5003 - 5010.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
C. Stremmel, E.A. Greenfield, E. Howard, G.J. Freeman, and V.K. Kuchroo
B7-2 Expressed on EL4 Lymphoma Suppresses Antitumor Immunity by an Interleukin 4-dependent Mechanism
J. Exp. Med., March 15, 1999; 189(6): 919 - 930.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. G. Agadjanyan, J. J. Kim, N. Trivedi, D. M. Wilson, B. Monzavi-Karbassi, L. D. Morrison, L. K. Nottingham, T. Dentchev, A. Tsai, K. Dang, et al.
CD86 (B7-2) Can Function to Drive MHC-Restricted Antigen-Specific CTL Responses In Vivo
J. Immunol., March 15, 1999; 162(6): 3417 - 3427.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. R. Maxwell, J. D. Campbell, C. H. Kim, and A. T. Vella
CD40 Activation Boosts T Cell Immunity In Vivo by Enhancing T Cell Clonal Expansion and Delaying Peripheral T Cell Deletion
J. Immunol., February 15, 1999; 162(4): 2024 - 2034.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. M. Slavik, J. E. Hutchcroft, and B. E. Bierer
CD80 and CD86 Are Not Equivalent in Their Ability to Induce the Tyrosine Phosphorylation of CD28
J. Biol. Chem., January 29, 1999; 274(5): 3116 - 3124.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. N. La Motte, A. H. Sharpe, J. A. Bluestone, and M. B. Mokyr
Importance of B7-1-Expressing Host Antigen-Presenting Cells for the Eradication of B7-2 Transfected P815 Tumor Cells
J. Immunol., December 15, 1998; 161(12): 6552 - 6558.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. E. Fields, R. J. Finch, G. S. Gray, R. Zollner, J. L. Thomas, K. Sturmhoefel, K. Lee, S. Wolf, T. F. Gajewski, and F. W. Fitch
B7.1 Is a Quantitatively Stronger Costimulus Than B7.2 in the Activation of Naive CD8+ TCR-Transgenic T Cells
J. Immunol., November 15, 1998; 161(10): 5268 - 5275.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. J. Sigal, H. Reiser, and K. L. Rock
The Role of B7-1 and B7-2 Costimulation for the Generation of CTL Responses In Vivo
J. Immunol., September 15, 1998; 161(6): 2740 - 2745.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Hermann, M. Rubio, T. Nakajima, G. Delespesse, and M. Sarfati
IFN-{alpha} Priming of Human Monocytes Differentially Regulates Gram-Positive and Gram-Negative Bacteria-Induced IL-10 Release and Selectively Enhances IL-12p70, CD80, and MHC Class I Expression
J. Immunol., August 15, 1998; 161(4): 2011 - 2018.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. M. Challita-Eid, M. L. Penichet, S.-U. Shin, T. Poles, N. Mosammaparast, K. Mahmood, D. J. Slamon, S. L. Morrison, and J. D. Rosenblatt
A B7.1-Antibody Fusion Protein Retains Antibody Specificity and Ability to Activate Via the T Cell Costimulatory Pathway
J. Immunol., April 1, 1998; 160(7): 3419 - 3426.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. H. Horspool, P. J. Perrin, J. B. Woodcock, J. H. Cox, C. L. King, C. H. June, D. M. Harlan, D. C. St. Louis, and K. P. Lee
Nucleic Acid Vaccine-Induced Immune Responses Require CD28 Costimulation and Are Regulated by CTLA4
J. Immunol., March 15, 1998; 160(6): 2706 - 2714.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Kozono, R. Abe, H. Kozono, R. G. Kelly, T. Azuma, and V. M. Holers
Cross-Linking CD21/CD35 or CD19 Increases Both B7-1 and B7-2 Expression on Murine Splenic B Cells
J. Immunol., February 15, 1998; 160(4): 1565 - 1572.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Dunussi-Joannopoulos, G. Dranoff, H. J. Weinstein, J. L.M. Ferrara, B. E. Bierer, and J. M. Croop
Gene Immunotherapy in Murine Acute Myeloid Leukemia: Granulocyte-Macrophage Colony-Stimulating Factor Tumor Cell Vaccines Elicit More Potent Antitumor Immunity Compared With B7 Family and Other Cytokine Vaccines
Blood, January 1, 1998; 91(1): 222 - 230.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. M. Putzer, M. Hitt, W. J. Muller, P. Emtage, J. Gauldie, and F. L. Graham
Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression
PNAS, September 30, 1997; 94(20): 10889 - 10894.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Bounou, N. Dumais, and M. J. Tremblay
Attachment of Human Immunodeficiency Virus-1 (HIV-1) Particles Bearing Host-encoded B7-2 Proteins Leads to Nuclear Factor-kappa B- and Nuclear Factor of Activated T Cells-dependent Activation of HIV-1 Long Terminal Repeat Transcription
J. Biol. Chem., February 23, 2001; 276(9): 6359 - 6369.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.